Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2024-08-16 00:00:00 ET · period of report 2024-08-14 · accession 0001415889-24-021480 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-16 | 2024-08-14 | ALXO | Randolph Sophia | Chief MEDICAL Off | S - Sale | $2.58 | -1,365 | 325.7K | -0.4% | -$3,522 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-14 | S | D | 1,365 | $2.58 | 325,711 | D | — | — |